Applicability of pan-TRK immunohistochemistry for identification of NTRK fusions in lung carcinoma
Abstract In the last two decades, various therapies have been introduced for lung carcinoma patients, including tyrosine-kinase inhibitors for different mutations. While some of them are specific to specific tumor types, others, like NTRK1–3 fusions, are found in various solid tumors. The occurrence...
Guardado en:
Autores principales: | Simon Strohmeier, Iva Brcic, Helmut Popper, Bernadette Liegl-Atzwanger, Jörg Lindenmann, Luka Brcic |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a1931cd4b02e42c9bec476b343ff09ed |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
NTRK fusion in Japanese colorectal adenocarcinomas
por: Yuya Yamashiro, et al.
Publicado: (2021) -
NTRK Gene Fusion Detection in Atypical Spitz Tumors
por: Rocco Cappellesso, et al.
Publicado: (2021) -
Dermoscopic Features of Spitz Tumor With LMNA-NTRK1 Fusion
por: Ben J. Friedman, et al.
Publicado: (2020) -
NTRK1/TrkA Signaling in Neuroblastoma Cells Induces Nuclear Reorganization and Intra-Nuclear Aggregation of Lamin A/C
por: Lukas Funke, et al.
Publicado: (2021) -
ALK rearranged non–small cell lung carcinoma with EML4-NTRK3 fusion as a possible mechanism of resistance to third-generation ALK inhibitors
por: Elena Corral de la Fuente, et al.
Publicado: (2021)